US Diabetes Devices Industry Overview
The United States diabetes care devices market is semi-consolidated, with few significant and generic players. The mergers and acquisitions between the players, like the acquisition of TypeZero Technologies by Dexcom, are paving the way for automated insulin delivery. The acquisition has sent Dexcom ahead on its way in the race to create an artificial pancreas system, rather than merely offering a boost to the continuous glucose monitoring devices market. There have been constant innovations driven by manufacturers such as Abbott and Medtronic, while also adhering to organic growth strategies, which is evident from the R&D spending of these companies.
US Diabetes Devices Market Leaders
-
Abbott
-
Dexcom
-
Becton Dickinson
-
Medtronic
-
F. Hoffmann-La Roche AG
- *Disclaimer: Major Players sorted in no particular order
